Healthcare
With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.
Contact advisor![](https://www.oaklins.com/uploads/sites/5/2022/03/HEALTHCARE-detail.2022.jpg)
Camelia pharmacy chain has been acquired by Medigate Management UAB
CGP Management UAB has sold the Camelia pharmacy chain (UAB Nemuno vaistinė and subsidiaries) to Medigate Management UAB.
Learn moreDPC has been acquired by Innova/6 SCA SICAV-RAIF
Innova/6 SCA SICAV-RAIF has acquired stakes in three companies operating in the dental services market in Central and Eastern Europe – the Lithuanian chain Clinic DPC and Polish Dentaurus and Medicadent clinics. Innova, in cooperation with the founding doctors, will develop a leading, independent regional dental group.
Learn moreBaltCap has sold InMedica to INVL Baltic Sea Growth Fund
BaltCap and a founder of InMedica have sold the company to INVL Baltic Sea Growth Fund. Financial details have not been disclosed.
Learn more![](/api/deal-client-photo/106511/deal-client-photo.jpg)
Alvydas Barsteiga
Member of the Board, CGP Management
Read more![](/api/deal-client-logo/106511/deal-client-logo.png)
Reshaping industries: M&A highlights and strategic vision
QUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the adaptability of various industries to evolving market conditions and strategic imperatives.
Learn more![](https://d21buns5ku92am.cloudfront.net/68798/images/544504-q2%202024%20hero-0fafbe-large-1719927574.jpg)
Talk to our local advisors
Meet our global industry specialists
Michael S. Goldman
Oaklins TM Capital